Form4.ai tracks every SEC insider trade in real time. See every ORKA insider filing with a free account — no card.
See every ORKA insider filing — free account, no card.
Free accountOruka Therapeutics, Inc. (ORKA) has 18 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $2.3M. Most recent filing: Nov. 2, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 2, 2026 SEC filing | Klein Lawrence Otto Chief Executive Officer | Cashless exercise | $2,195,125 | — |
| Oct 20, 2026 SEC filing | Quinlan Paul T General Counsel | Cashless exercise | $636,535 | — |
| Oct 15, 2026 SEC filing | Goncalves Joana Chief Medical Officer | Cashless exercise | $475,768 | — |
Create a free account to see all 18 ORKA filings from the last 90 days. No card needed.
Create free accountWant ORKA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.